Harmony Biosciences Holdings Inc’s: Contrasting Stock Performances in a Volatile Market

The market performance of Harmony Biosciences Holdings Inc’s stock has been harmonious in recent times. Over the last year, the company’s stock reached its highest point at $39.26 on 09/13/23, while the lowest value for the same duration was $18.61 on 10/13/23.

52-week price history of HRMY Stock

A stock’s 52-week high and low prices can reveal much about its current status and future trajectory. Harmony Biosciences Holdings Inc’s current trading price is -11.96% away from its 52-week high, while its distance from the 52-week low is 85.75%. The stock’s price range during this period has spanned from $18.61 to $39.26. In the Healthcare sector, the Harmony Biosciences Holdings Inc’s shares surpassed a trading volume of approximately 0.73 million for the day, which was noticeably higher compared to the average daily volume of 9.0.39 million over the past three months.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Market Capitalization and Financial Performance: An In-Depth Look

Harmony Biosciences Holdings Inc (HRMY) has experienced a quarterly rise of 15.85% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 1.96B and boasts a workforce of 246 employees.

Making Sense of Trading Volume and Moving Average Data

Based on Barchart.com data, the company’s moving average over the 100-day period was 30.86, with a change in price of +1.70. Similarly, Harmony Biosciences Holdings Inc recorded 401,830 in trading volume during the last 100 days, posting a change of +5.17%.

Examining HRMY’s Debt-to-Equity Ratio: What You Need to Know

The debt-to-equity (D/E) ratio is a crucial measure that sheds light on a company’s financial health and market standing. It is determined by dividing a company’s overall liabilities by its shareholders’ equity, showing the extent of a company’s debt usage in financing its assets compared to the shareholders’ equity. At the time of writing, the total D/E ratio for HRMY stands at 0.42. Similarly, the long-term debt-to-equity ratio is also 0.34.

HRMY Stock Stochastic Average

Today, Harmony Biosciences Holdings Inc’s raw stochastic average for the past 50 days stands at 96.77%, indicating a rise from the raw stochastic average of the last 20 days, which was 96.77%. Moreover, the company’s Stochastic %K and %D values over the past 20 days were 88.75% and 78.07% respectively.

HRMY Stock Price Performance Analysis

The stock price performance over the year has been a mixed bag, resulting in a range of outlooks from optimistic to pessimistic depending on the observer. The index has shown a price gain of 7.03% this year. Over the last six months, there has been a weaker performance of 8.10%. The price of HRMY fallen by 13.27% during the last 30 days period. For the last 5-days stocks have improved 13.64%.

Most Popular